• Etanercept (BENEPALI)
  • Infliximab (FLIXABI)
    • Study proposals are currently being considered for support when related to:

      • Adult rheumatoid arthritis
      • Adult psoriatic arthritis
      • Adult axial spondyloarthritis, including ankylosing spondylitis and non-radiographic spondyloarthritis
      • Adult plaque psoriasis
      • Adult and paediatric Crohn’s disease
      • Adult and paediatric ulcerative colitis

      Established areas of research include:

      • Immunogenicity
      • Maintenance of response
      • Prediction and optimization of response
      • Treatment modalities
      • Patient reported outcomes
      • Patient satisfaction
      • Healthcare resource utilisation

      Please note that ONLY proposals from within the EU will be considered by Biogen.

      Research support is awarded on a highly competitive basis, and submission of research proposals in these areas of interest does not guarantee that support will be awarded.